View Clinical Trial (Medical Research Study)

A Study of Patients With Relapsing Remitting Multiple Sclerosis - NCT00882999-44320(Clinical Trial 543732)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Akron
State:  
OH
Zip Code: 44320
Conditions: Relapsing-Remitting Multiple Sclerosis
Purpose: To look at the ability of LY2127399 to reduce magnetic resonance imaging (MRI) lesions at 12, 16, 20, and 24 weeks compared to placebo.
Study summary:
Criteria: Inclusion Criteria: - 18 through 64 years of age diagnosed with relapsing-remitting multiple sclerosis (RRMS), who can walk without aid or rest for at least 200 meters (approximately 1/10 of a mile). - Women who can become pregnant must use birth control. Exclusion Criteria: - Have had a live vaccination within 12 weeks before randomization, or intend to have a live vaccination during the course of the study. - Have had had recent surgery or are scheduled to have surgery during the study. - Are immunocompromised or have evidence of active infection (such as hepatitis, tuberculosis or, human immunodeficiency virus [HIV]). - Have been on certain drugs that are being studied for RRMS or have recently received prescription drugs to treat RRMS. - Have had a recent serious infection. - Have serious or uncontrolled illnesses other than RRMS. - Have clinically significant blood test values. - Have multiple or severe drug allergies. - Have contraindications for magnetic resonance imaging (MRI; "scanning") or claustrophobia (fear of an enclosed space) that cannot be managed.
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: September 9, 2010
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.